RNXT - RenovoRx - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RNXT is currently covered by 2 analysts with an average price target of $8.75. This is a potential upside of $8.05 (417.75%) from yesterday's end of day stock price of $1.69.

RenovoRx's activity chart (see below) currently has 5 price targets and 8 ratings on display. The stock rating distribution of RNXT is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for RNXT is $14.5, Lowest price target is $3, average price target is $8.75.

Most recent stock forecast was given by EDWARD WOO from ASCENDIANT on 28-Aug-2026. First documented stock forecast 07-Oct-2021.

Best performing analysts who are covering RNXT - RenovoRx:

Edward Woo Jason Mccarthy Scott Henry Swayampakula Ramakanth

Currently out of the existing stock ratings of RNXT, 4 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 05-Jun-2025

$14.5

$12.74 (723.86%)

$13.5

18 days ago
(28-Aug-2026)

0/3 (0%)

$12.83 (768.26%)

Buy Since 27-Mar-2025

$3

$1.24 (70.45%)

$3

5 months 7 days ago
(08-Apr-2026)

0/4 (0%)

$2.06 (219.15%)

Buy Since 02-Nov-2021

$4

$2.87 (253.98%)

2 years 7 months 13 days ago
(02-Feb-2024)

0/2 (0%)

$2.3 (135.29%)

Hold Since 15-Nov-2023

$15

2 years 10 months ago
(15-Nov-2023)

0/2 (0%)

$15 (0.00%)

Show more analysts

Please expand the browser size to see the chart

Which analyst most recently updated their price target on RNXT (RenovoRx)?

Edward Woo

Which analyst has the current lower performing score on RNXT (RenovoRx) with a proven track record?

SWAYAMPAKULA RAMAKANTH

Which analyst has the most public recommendations on RNXT (RenovoRx)?

Edward Woo works at ASCENDIANT and has 21 price targets and 12 ratings on RNXT

Which analyst is the currently most bullish on RNXT (RenovoRx)?

Edward Woo with the highest potential upside of $12.74

Which analyst is the currently most reserved on RNXT (RenovoRx)?

Jason Mccarthy with the lowest potential downside of -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?